Reply to Comment on low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study

Cancer. 2021 Mar 15;127(6):976-978. doi: 10.1002/cncr.33281. Epub 2020 Oct 23.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Fusion Proteins, bcr-abl
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Leukemia, Myeloid*
  • Protein Kinase Inhibitors / adverse effects
  • Retrospective Studies

Substances

  • Protein Kinase Inhibitors
  • Fusion Proteins, bcr-abl